Amplyx Pharmaceuticals : Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia

Press/Media: Press / Media

PeriodSep 16 2019

Media coverage

1

Media coverage

  • TitleAmplyx Pharmaceuticals : Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletMarketScreener.com
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII